Trial intelligence / Profile preview

Flexible vs fixed-dose pregabalin as first-line add-on for focal seizures

2006-004201-26Phase 4Terminated

Sponsor
Neuro-Consil
Start
Apr 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of pregabalin in epilepsy (2 arms), sponsored by Neuro-Consil. Primary endpoint: Complete seizure control rate. Started Apr 2007; status: terminated.

02

Drugs

pregabalin
03

Conditions

epilepsy

Beyond the preview

Go deeper on 2006-004201-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004201-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call